Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
10/2008
10/02/2008WO2008116669A1 Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of influenza a viral infection
10/02/2008WO2008116641A2 Oleyl phosphocholine
10/02/2008WO2008116468A2 Mhc peptide complexes and uses thereof in infectious diseases
10/02/2008WO2008116385A1 Caffeoyl quinic acid derivatives containing nitrogen, and preparation method, pharmaceutically composition and usage thereof
10/02/2008WO2008116368A1 A method for preparing antigens of foot-and-mouth disease virus
10/02/2008WO2008116319A1 Bioproduction of ferulic acid and uses thereof
10/02/2008WO2008116293A1 Multivalent heterobifunctional polymers and methods of their use
10/02/2008WO2008116265A1 Peptides with anitfungal activity
10/02/2008WO2008106130A3 Tertiary amine substituted peptides useful as inhibitors of hcv replication
10/02/2008WO2008098955A3 Antibacterial combination of a tricyclic carbapenem and an antibiotic
10/02/2008WO2008090287A3 Use of at least one botulism neurotoxin for treating the pain induced by therapeutic treatments for the aids virus
10/02/2008WO2008086612A8 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity
10/02/2008WO2008078056A3 Method for amplifying hcv in aedes mosquitoes
10/02/2008WO2008073142A3 Novel inhibitors of beta-lactamase
10/02/2008WO2008062167A3 Melatonin derivatives and their use as antioxidants
10/02/2008WO2008020904A3 Method for reducing the risk of or preventing infection due to surgical or invasive medical procedures
10/02/2008WO2008017826A3 Immunogenic proteins of burkholderia pseudomallei and uses thereof
10/02/2008WO2007139968A3 Triazole compounds that modulate hsp90 activity
10/02/2008WO2007134327A3 Neutralizing antibodies to influenza viruses
10/02/2008WO2007044893A3 Compounds and methods for inhibiting hepatitis c viral replication
10/02/2008US20080242732 Administering pharmaceutical orally at dose-delivery rate sufficient to provide clinically effective blood level in portal vein, less than required for blood level in peripheral circulation to provide dose-delivery selective in liver
10/02/2008US20080242714 alpha -[hexahydro-5-hydroxy-4-(3-hydroxy-4-methyl-1-octenyl)-2H-cyclopenta[b]furan-2-ylidene]-1H-tetrazole-5-2E-pentanenitrile; inhibits release of Th-1 cytokines while sparing expression of Th-2 cytokines; viricide; respiratory diseases associated with influenza A viruses
10/02/2008US20080242681 N-4-(6-(Hetero)Aryl-Pyrimidin-4-Ylaminophenyl)-Benzenesulfonamides as Kinase Inhibitors
10/02/2008US20080242676 Drug resistant Mycobacterium tuberculosis
10/02/2008US20080242652 Indole derivatives and their metal conjugates and uses thereof
10/02/2008US20080242636 Modified cyclodextrin sulfate-71 (terigyn) as a microbicide agent
10/02/2008US20080242632 Targets two or more Dna sequence ; anticancer agents, therapy for infections, antiinflammatory agents, autoimmune diseases; respiratory system disorders; liver disorders
10/02/2008US20080242630 Fusion proteins of mycobacterium tuberculosis
10/02/2008US20080242614 Polypeptide containing valine or proline; therapy for infections
10/02/2008US20080242605 Prevent binding of formyl methionine-leucine-phenylalanine and, or protein to granulocytes; antiinflammatory agents; viricides; HIV infections
10/02/2008US20080242602 Methods and Compositions For the Inhibition of Hiv-1 Replication
10/02/2008US20080242601 Selective Inhibition of Nf-Kappab Activiation by Peptides Designed to Disrupt Nemo Oligomerization
10/02/2008US20080242597 Antibiotic compounds
10/02/2008US20080241961 Drosophila g protein coupled receptors, nucleic acids, and mehtods related to the same
10/02/2008US20080241923 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulin for treatment and prevention of viral infection, inflammatory, autoimmune, graft rejection and cardivascular disorders
10/02/2008US20080241859 Using aglycoprotein 10B antibody as diagnostic tool in detection of cell proliferative disorders associated with chronic viral diseases
10/02/2008US20080241275 Gallium nitrate, gallium maltolate, gallium citrate, gallium phosphate, gallium chloride, gallium fluoride, gallium carbonate, gallium formate; antimicrobial agent is vancomycin, linezolid, clarithromycin, amoxicillin, metronidazole, omeprazole, bismuth subsalicylate; excludes Pseudomonas, Legionella
10/02/2008US20080241271 Nasal foams to reduce the ability of a virus to infect a human being; water, glycerin, Crodasinic LS30, xanthan gum, iota carrageenan, sodium hydroxide, benzalkonium chloride, zinc gluconate
10/02/2008US20080241265 Pharmaceutical Combinations Containing Lamivudine, Stavudine and Nevirapine
10/02/2008US20080241259 Method for production of bioresorbable microparticles, microparticles thus obtained and use thereof
10/02/2008US20080241190 Vaccination of horses against lawsonia intracellularis
10/02/2008US20080241189 Sequential oral, intranasal, or intramuscular administration of a replication-defective adenovirus comprising a first heterologous expression cassette, and an adeno-associated virus comprising a second heterologous expression cassette; side effect reduction in vaccine carriers
10/02/2008US20080241187 Stabilization of viral compositions
10/02/2008US20080241186 Nucleic acid vaccines for prevention of flavivirus infection
10/02/2008US20080241185 A matrix of a crosslinked polyampholyte having a cavity capable of selectively binding to a template of microorganisms, bacteria, proteins, nucleic acids; cartridges for blood dialysis (HIV); purification by washing a chromatography column loaded with a cell/tissue extracted virus followed by elution
10/02/2008US20080241181 Streptococcal antigenic protein for use in generation of vaccines to prevent microorganismal infection
10/02/2008US20080241179 Structural proteins of fish pancreatic disease virus and uses thereof
10/02/2008US20080241167 Inhibiting membrane fusion between human immunodeficiency virus and chemokine receptor-5 expressing cells using receptor specific immunoglobulins
10/02/2008US20080241165 Controlling extracellular protein degradation and/or clearance via modulation of tissue plasminogen activator activity; treating diabetic, autoimmune, cardiovascular, blood and nervous system disorders
10/02/2008US20080241162 Hepatitis c viral E2 glycoprotein specific immunoglobulin for use in prevention and treatment of hepatitis infection
10/02/2008US20080241158 G-protein coupled receptors for use in identifying modulators for treatment and prevention of cell proliferative, neurological, cardiovascular, gastrointestinal, autoimmune/inflammatory, metabolic and viral disorders
10/02/2008US20080241156 Inhibitors of hepatitis C virus
10/02/2008US20080241155 Death domain containing receptor 4
10/02/2008US20080241151 Neisserial peptides for use in developing vaccine for prevention and treatment of menigococcal septicemia and meningitis
10/02/2008US20080241136 Using cc-chemokine receptor 2 (CCR2) specific immunoglobulins for use in treatment and prevention of skin disorders
10/02/2008US20080241122 Fluidic mixture comprising benzoic acid and pepsin for use in treatment, disinfection and removal of dental carries
10/02/2008US20080241099 Inhibitors of MBP 85-99 or proteolipid protein (PLP) 40-60-specific HLA-DR-2-restricted T cell clones; multiple sclerosis; rheumatoid arthritis; solid phase synthesis; kits
10/02/2008US20080241081 Amide compound or salt thereof, and biofilm remover containing the same
10/02/2008CA2685729A1 Artificial invaplex
10/02/2008CA2684655A1 Oral pharmaceutical preparation for colon-specific delivery
10/02/2008CA2682145A1 A treatment
10/02/2008CA2682050A1 Pharmaceutical composition comprising a cytokine
10/02/2008CA2681921A1 Peptides with anitfungal activity
10/02/2008CA2681766A1 Multivalent heterobifunctional polymers and methods of their use
10/02/2008CA2681593A1 Preventive or therapeutic composition for liver disease
10/02/2008CA2681393A1 New imidazolo-heteroaryl derivatives and biological applications thereof
10/02/2008CA2681379A1 Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of influenza a viral infection
10/02/2008CA2680517A1 Novel pyridinecarboxylic acid (2-aminophenyl)amide derivative having urea structure
10/02/2008CA2680018A1 Combination medicaments for treating bacterial infections
10/01/2008EP1975238A1 Gene construct, vector and dna vaccine for the vaccination of aquatic animals
10/01/2008EP1975235A2 Porcine circovirus vaccine in recombinant poxvirus
10/01/2008EP1975173A1 Anti-Retroviral Immunogens, Preparation and Use
10/01/2008EP1975172A2 High affinity TGFß nucleic acid ligands and inhibitors
10/01/2008EP1975163A1 Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of influenza a viral infection
10/01/2008EP1974744A1 Immunization through oral administration of a vaccine with an edible product
10/01/2008EP1974720A1 Use of a vitreoscilla filiformis lipopolysaccharide fraction as an agent for stimulating the synthesis of anti-microbial skin peptides
10/01/2008EP1974048A1 Method for preparing antibodies selective for activating fc receptors
10/01/2008EP1973906A1 Hydroxydihydropyridopy razine-1,8-diones and methods for inhibiting hiv integrase
10/01/2008EP1973902A2 3-heterocyclylacrylamide compounds as fabi inhibitors and antibacterial agents
10/01/2008EP1973898A1 Pdf inhibitors
10/01/2008EP1973887A1 Aza heterocyclics for the treatment of malaria or aids
10/01/2008EP1973537A1 Carbamate antibiotics
10/01/2008EP1713477B1 Combination of voriconazole and an antifungal cyp2c19 inhibitor
10/01/2008EP1654239A4 Peptide deformylase inhibitors
10/01/2008EP1608377B1 Pharmaceutical compositions comprising inhibitors of fab i and further antibiotics
10/01/2008EP1355629B1 Solid phase dispersion of quinolone- or naphthyridonecarboxylic acids
10/01/2008CN101277971A Vaccines against AIDS comprising CMV/R - nucleic acid constructs
10/01/2008CN101277950A Inhibitors of serine proteases
10/01/2008CN101277740A Antituberculous composition comprising oxazole compounds
10/01/2008CN101277717A PCV-2 vaccine
10/01/2008CN101277709A A medical composition for treating wounds
10/01/2008CN101277698A Quinoline derivatives as antibacterial agents
10/01/2008CN101277696A Quinoline derivatives as antibacterial agents
10/01/2008CN101277695A Quinoline derivatives as antibacterial agents
10/01/2008CN101277682A Amorphous efavirenz and production thereof
10/01/2008CN101275143A Nucleic acid encoding hyaluronan synthase and methods of use
10/01/2008CN101275142A Newcastle disease virus infectious clones, vaccines and diagnostic assays
10/01/2008CN101275132A SiRNA capable of inhibiting influenza A virus replication and coding sequence thereof
10/01/2008CN101274959A Proteinase k resistant surface protein of neisseria meningitidis
10/01/2008CN101274957A Human cytomegalovirus M epitope and application thereof to medical research field
1 ... 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 ... 1798